Article History
Received: 15 April 2021
Accepted: 27 June 2021
First Online: 28 July 2021
Declarations
:
: The study protocol was approved by the Institutional Review Board of the Bamrasnaradura Infectious Diseases Institute (S059h/63_ExPD) and was conducted in compliance with the ethical principles of the Helsinki Declaration. Informed consent was waived by the Institutional Review Board which approved the study. All methods were carried out in accordance with the International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines.
: Not applicable.
: The authors declare that they have no competing interests.